title: On the cutting edge of acute coronary syndromes: adding oral factor Xa-inhibition with darexaban to dual antiplatelet therapy: the RUBY-1 trial.
authors: Department of Cardiology, Aarhus University Hospital, Skejby, DK-8200 Aarhus N, Denmark. steendk@dadlnet.dk
authors: Steen D
authors: SD
authors: Kristensen
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D065427:Factor Xa Inhibitors; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D065427:Factor Xa Inhibitors